CSI Market
Sign In | Register

Moonlake Immunotherapeutics (MLTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access MLTX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Moonlake Immunotherapeutics's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent334.52
Available-for-sale Securities, Debt Securities, Current MA59.45
Cash & Short-term Investments393.00
Other Receivables, Net, Current4.87
Prepaid Expense, Current AS22.86
Total Current Assets421.69
Equipment/Property/Plant Net0.58
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent2.16
Operating Lease Right Of Use Asset1.57
Total Assets424.43
Liabilities
Accrued Liabilities And Other Liabilities14.69
Other Liabilities, Current30.79
Total Current Liabilities45.48
Long-term debt74.10
Total Long-term Debt74.10
Defined Benefit Pension Plan, Liabilities, Noncurrent PE0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current29.55
Operating Lease Liability Noncurrent0.37
Total Liabilities119.95
Stockholders' Equity
Common Stock Value-
Common Stock Value0.01
Additional Paid In Capital Common Stock766.78
Retained Earnings / Accumulated Deficit-462.91
Other Equity3.61
Common Stockholder's Equity307.48
Non-controlling interests & other0.00
Total Stockholder's Equity304.48
Liabilities & Stockholder's Equity424.43
4 historic quarters locked

Sign in to unlock the full Moonlake Immunotherapeutics balance sheet history.

Sign In Create Free Account

About Moonlake Immunotherapeutics Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: mnlk-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001821586-26-000002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License